| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |